Q1 2022 · 13F-HR
Antipodean Advisors LLCholdings as filed
Filed 2022-05-16 · accession 0000919574-22-003479
$138,108
Reported value
6
Positions
2022-03-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 146869102 | CVNA | CARVANA CO | $48,312 | 35.0% | 405,000 | Common | SOLE |
| 81141R100 | SE | SEA LTD | $41,927 | 30.4% | 350,000 | Common | SOLE |
| 14161W105 | CDLX | CARDLYTICS INC | $35,121 | 25.4% | 638,800 | Common | SOLE |
| 046513107 | ATRAGBX | ATARA BIOTHERAPEUTICS INC | $9,290 | 6.73% | 1,000,000 | Common | SOLE |
| 14171W103 | — | CAREMAX INC | $3,175 | 2.30% | 425,000 | Common | SOLE |
| 92189F403 | — | VANECK ETF TRUST | $283 | 0.20% | 50,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.